530125-BOM

Samrat Pharmachem Ltd.

251.00+0.0 (+0.00%)
27 Jul, 2:59 PM

Annual Reports and Financial Documents

Samrat Pharmachem Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Samrat Pharmachem Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Appointment of Statutory Auditor/s17 Jul 2026
    Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
    Appointment of Statutory Auditors for the company from 34th Annual General Meeting to 39th Annual General Meeting
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201817 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30th June 2026
  • Board Meeting30 Jun 2026
    Board Meeting Intimation for Notice Of Board Meeting For Un-Audited Financial Results For The Quarter Ended June 30, 2026
    Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Approval of Un-Audited Financial ....
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window for the quarter ended June 30, 2026
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window for the quarter ended June 30, 2026
  • Newspaper Publication4 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Extract of the Standalone Audited Financial Results for the year ended March 31, 2026.
  • Outcome of Board Meeting30 May 2026
    Board Meeting Outcome for Outcome Of The Board Meeting
    The Board considered and adopted the financial results for the quarter and year ended March 31, 2026
  • Reg.24(A)-Annual Secretarial Compliance30 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance for the year ended 31-March-2026
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A7 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate u/r 74(5) for the quarter ended March 31, 2026
  • Credit Rating30 Mar 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Crisil Limited has upgraded its rating to CRISIL BB/STABLE/ CRISILA4+
  • Closure of Trading Window25 Mar 2026
    Closure of Trading Window
    Closure of Trading Window from 01-04-2026 till 48 hours after the declaration of Audited Financial Results for the year ended 31/03/2026
  • Board Meeting25 Mar 2026
    Board Meeting Intimation for Audited Financial Results For The Financial Year Ended March 31, 2026
    Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
  • Newspaper Publication18 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication - Extract of Un-audited financial results for the quarter ended 31 December, 2025
  • Outcome of Board Meeting13 Feb 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Held Today
    The Board has considered and took on record the Un-audited financial results of the company for the quarter ended December 31, 2025.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201812 Jan 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate u/r 74(5) for the quarter ended 31/12/2025
  • Board Meeting29 Dec 2025
    Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31, 2025
    Samrat Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the un-audited financial ....
  • Closure of Trading Window29 Dec 2025
    Closure of Trading Window
    The Trading Window of the Company shall remain closed from Thursday, January 1, 2026 till 48 hours after the declaration of Un-audited financial results for the quarter ended December 31, 2025.
  • Credit Rating2 Dec 2025
    Announcement under Regulation 30 (LODR)-Credit Rating
    Crisil Ltd has downgraded its rating to "CrisilBB+/Negative/CrisilA4+"
  • Newspaper Publication20 Nov 2025
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication - Extract of Results for the quarter and half year ended September 30, 2025

Frequently Asked Questions

Where can I download the annual report of Samrat Pharmachem Ltd.?
Annual reports of Samrat Pharmachem Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Samrat Pharmachem Ltd.?
Quarterly earnings results and presentations of Samrat Pharmachem Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Samrat Pharmachem Ltd. publish earnings call transcripts?
Earnings call transcripts of Samrat Pharmachem Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Samrat Pharmachem Ltd.?
Investor presentations and annual day presentations of Samrat Pharmachem Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Samrat Pharmachem Ltd.?
Corporate announcements and regulatory filings of Samrat Pharmachem Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Samrat Pharmachem Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Samrat Pharmachem Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Samrat Pharmachem Ltd.?
The ISIN (International Securities Identification Number) of Samrat Pharmachem Ltd. is INE103E01016. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Samrat Pharmachem Ltd. listed?
Samrat Pharmachem Ltd. is listed on NSE and BSE. The NSE symbol is 530125-BOM and the BSE code is -.
Where can I find the shareholding pattern of Samrat Pharmachem Ltd.?
The quarterly shareholding pattern of Samrat Pharmachem Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Samrat Pharmachem Ltd. on Sharpely?
Share price data for Samrat Pharmachem Ltd. is updated as of 27 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.